Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions

被引:66
作者
Kudlow, Paul A. [1 ]
McIntyre, Roger S. [2 ,3 ]
Lam, Raymond W. [4 ,5 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Hlth Network, Head Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada
[4] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada
[5] Univ British Columbia Hosp, Mood Disorders Ctr Excellence, Vancouver, BC V6T 2A1, Canada
基金
加拿大健康研究院;
关键词
MAJOR DEPRESSIVE DISORDER; STAR-ASTERISK-D; EARLY IMPROVEMENT; EARLY PREDICTION; DOUBLE-BLIND; TIME-COURSE; FLUOXETINE; ONSET; TRAJECTORIES; GUIDELINES;
D O I
10.1007/s40263-014-0171-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Studies have found that up to two-thirds of patients with major depressive disorder (MDD) do not fully respond to the first antidepressant. While switching antidepressants is a common strategy for antidepressant non-responders, there is still a lack of consensus about the optimal timing of a switch. Many clinicians wait for 6-12 weeks before considering a switch. The objectives of this paper are to (1) review the evidence for positive and negative predictive value (NPV) of early improvement at 2-4 weeks to predict final antidepressant response; (2) review randomized controlled trials (RCTs) that examine early switching strategies; and (3) provide future research directions and clinical recommendations for timing of antidepressant switching. We conducted a literature search for English-language studies via PubMed and Google Scholar, from 1984 to May 2013, with the following terms: 'antidepressants', 'MDD', 'time course', 'trajectory', 'early response', 'onset', 'delayed response', 'early improvement', 'predictors', 'switch', 'combination therapy', and 'augmentation'. Replicated evidence indicates that lack of early improvement (e.g. < 20 % reduction in a depression scale score) at 2-4 weeks can be an accurate predictor to identify eventual non-responders. The NPVs suggest that only about one in five patients with lack of improvement at 4 weeks will have a response by 8 weeks. Three RCTs examined early switch strategies, but results are inconsistent and comparisons limited by methodological differences. Future studies should incorporate a standard consensus definition of early improvement, discern whether the effect of early switching is specific to certain types of antidepressants, and determine whether early switch is superior to other strategies such as augmentation or combination. Notwithstanding these limitations, there is reasonable evidence to recommend earlier assessment for improvement. If there is no indication of early improvement at 2-4 weeks after starting an antidepressant, and taking into account other patient and clinical factors, a change in management can be considered.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 47 条
  • [1] Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
    Anderson, I. M.
    Ferrier, I. N.
    Baldwin, R. C.
    Cowen, P. J.
    Howard, L.
    Lewis, G.
    Matthews, K.
    McAllister-Williams, R. H.
    Peveler, R. C.
    Scott, J.
    Tylee, A.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (04) : 343 - 396
  • [2] How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database
    Baldwin, David S.
    Stein, Dan J.
    Dolberg, Ornah T.
    Bandelow, Borwin
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (04) : 269 - 275
  • [3] The early improvement of depressive symptoms as a potential predictor of response to antidepressants in depressive patients who failed to respond to previous antidepressant treatments. Analysis of naturalistic data
    Bares, M.
    Novak, T.
    Kopecek, M.
    Stopkova, P.
    Kozeny, J.
    Hoeschl, C.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27 (07) : 522 - 527
  • [4] Early predictors of two month response with mianserin and selective serotonin reuptake inhibitors and influence of definition of outcome on prediction
    Berlin, I
    Lavergne, F
    [J]. EUROPEAN PSYCHIATRY, 1998, 13 (03) : 138 - 142
  • [5] Early Non-Response in Patients with Severe Depression Escitalopram Up-Titration versus Switch to Duloxetine
    Bose, Anjana
    Tsai, Joyce
    Li, Dayong
    [J]. CLINICAL DRUG INVESTIGATION, 2012, 32 (06) : 373 - 385
  • [6] Davidson Jonathan R T, 2010, J Clin Psychiatry, V71 Suppl E1, pe04, DOI 10.4088/JCP.9058se1c.04gry
  • [7] Gorwood P, 2014, EUR PSYCHIAT, V53, P54
  • [8] A RATING SCALE FOR DEPRESSION
    HAMILTON, M
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) : 56 - 62
  • [9] Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action
    Harmer, Catherine J.
    Goodwin, Guy M.
    Cowen, Philip J.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2009, 195 (02) : 102 - 108
  • [10] Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression
    Henkel, Verena
    Seemueller, Florian
    Obermeier, Michael
    Adli, Mazda
    Bauer, Michael
    Mundt, Christoph
    Brieger, Peter
    Laux, Gerhard
    Bender, Wolfram
    Heuser, Isabella
    Zeiler, Joachim
    Gaebel, Wolfgang
    Mayr, Andreas
    Moeller, Hans-Juergen
    Riedel, Michael
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 115 (03) : 439 - 449